Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Journal
Document Type
Year range
1.
Tumori ; 107(2 SUPPL):91, 2021.
Article in English | EMBASE | ID: covidwho-1571639

ABSTRACT

Background: Cancer patients (Pts) present an increased risk of a severe form of SARS-cov-2 disease because of immunodepression status induced by treatments and cancer. National and international organizations recommend vaccination against SARS-cov-2 in this specific population. An efficient vaccination procedure in oncologic Pts is particularly relevant. ASLVC Oncology spoke (North West Piedmont, Italy) includes two hospitals: one in Vercelli and one in Borgosesia. We report here our real life experience about SARS-Cov-2 vaccination in cancer patients, in both hospitals. Material and methods: Hospital Administration approved a local vaccination procedure for cancer pts on April 2021. Medical, nursing and administrative staff of Oncology Unit were trained for the vaccination of their Pts and worked out a specific disclosure. A member of a Voluntary Association welcomed and helped Pts. Each patient benefited from an individual medical examination with an oncologist before the first administration of the vaccine. Medical history, allergy and ongoing treatments were reviewed before administration. Blood tests were performed to every patient treated by chemotherapy. A consent form was signed. Information about Covid-19 status and vaccination were reported in the oncologic medical record. Results: Vaccines used for vaccination were Pfizer- BioNTech according to current guidelines. Two doses were scheduled three to four weeks apart. Since April 26th to May 19th in Vercelli there were 9 injection sessions;115 Pts.were vaccinated: 91 (79%) had first dose and 24 (21%) second;while in Borgosesia 45 Pts were vaccinated, 32 (73%) had first dose and 12 (27%) second. Nobody had acute reaction or serious adverse event, 20 (12.5%) Pts had late and mild adverse events. Most frequently reported adverse event were arm pain, arthralgia, muscle weakness, headache. Only one patient (0.6%) with a history of severe allergic reaction was vaccinated in intensive care. Conclusions: Vaccination against Sars-Cov-2 in cancer Pts is safe and is still ongoing in our hospitals. An appropriate and specific procedure permitted to manage and efficient vaccination in cancer Pts even through chemotherapy.

2.
Tumori ; 107(2 SUPPL):151-152, 2021.
Article in English | EMBASE | ID: covidwho-1571631

ABSTRACT

Background: Teenagers are at age when they start making decisive choices. Without adequate information on correct lifestyles they run health risks, particularly with regard to future cancers. However, they have curiosity, interest and strong desire to learn in medical issues. This trial was developed to promote knowledge of cancer development and prevention program by informing students about correct lifestyles by teaching, playing an educational game, involving them interactively both in presence and on digital platform. Methods: Since September 2019, medical oncologists with teachers from 2 first grade classes in two schools started a shared teaching path. Educational meetings were held for class presenting slides on neoplasms development and wrong lifestyles causing their onset. Slides were illustrated with comics. Students built with comics some of 90 boxes of a pathway similar to game of goose, set in their country in Middle Age. Players were two classes competing throwing dices to reach box number 90,equal to the years of cancer-free life expectancy conquered with correct lifestyle. Each box corresponded to a card like “tarot cards”, prepared to slow down the path, if it represented a wrong conduct or event, and to speed up otherwise. During the second year of class, lessons illustrated H&N with gastrointestinal cancers. Impact of course was evaluated through a questionnaire prepared by a dental hygienist and proposing a healthy snack at least once a week at school. Results: We performed 40 educational meetings of 30 minutes, followed by 20 minutes of play. Six medical oncologists, 1 psychologist, 1 dietician, 1 dental hygienist, 4 teachers actively contributed;4 classes joined the initiative, 92 teenagers participated in 15 in-presence meetings and 25 on online platform during COVID19. All contributed to build and enjoyed the game. They wanted to start following course directions by bringing to school a snack proposed by dietician once a week. Ten of them offered to participate in the peer education course in other classes. Fifty-two questionnaires were completed at the beginning of the course and re-proposed at the conclusion. Students answered: 52/52(100%) knew tumors of oral cavity, 37/52(71%) knew color of precancerous lesions, 42/52(79%) knew risk factors, 48/52(92%) replied they would never start to smoke. Conclusions: Teaching teenagers correct lifestyle preventing cancer by innovative method playing an educational game is achievable and can give results.

SELECTION OF CITATIONS
SEARCH DETAIL